for

Bybit Resumes Full Access for Indian Users, Reinforces Commitment to Compliance and Crypto Inclusion

DUBAI, UAE, Sept. 8, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has restored full access to…

4 months ago

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz (rilzabrutinib)

LOUISVILLE, Ky., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a…

4 months ago

NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness

TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone”…

4 months ago

Olympic Museum announces renewed collaboration with On Location, the Official Hospitality Provider for the Milano Cortina 2026 Olympic and Paralympic Winter Games

08 September 2025 - The Olympic Museum today announced that it has renewed its collaboration with On Location, the Official Hospitality Provider for…

4 months ago

Sirtex Receives Expanded CE Mark Approval for SIR-Spheres Y-90 Resin Microspheres

Broadened indication increases access to liver cancer treatment across Europe and CE-marked territories. WOBURN, Mass., Sept. 8, 2025 /PRNewswire/ --…

4 months ago

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder

Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi companyKER-0193, a novel, orally bioavailable…

4 months ago

Literacy for All in the Digital Era

Education Cannot Wait funding through its strategic partners provides foundational learning opportunities for the world's most vulnerable children to bridge…

4 months ago

New names set high standards for safety: Togg and firefly shake up the EV market

LEUVEN, BELGIUM – The chances are you won’t have heard of it and will never have seen one of its…

4 months ago

InnoCare Announces Approval of HIBRUKA (Orelabrutinib) for the Treatment of Marginal Zone Lymphoma in Singapore

BEIJING, Sept. 07, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer…

4 months ago

CATL Launches Shenxing Pro, Europe’s Optimal Solution for E-Mobility at IAA Mobility 2025

MUNICH, Sept. 7, 2025 /PRNewswire/ -- At CATL Open Day, the company unveiled Shenxing Pro, the world's first lithium iron…

4 months ago